Hikma Pharmaceuticals
LONDON, August 25, 2011 -
Hikma Pharmaceuticals reports lower-than-expected 3.2% increase in revenues for the first half but maintains its full-year outlook.
LONDON, March 16, 2011 - In a video interview with financial broadcaster www.cantos.com,
Hikma CEO Said Darwazah said all divisions were performing well as the pharma
group announced its 2010 preliminary results.
LONDON, October 29, 2010 - Hikma Pharmaceuticals, the multinational pharmaceutical group, announces
that it has signed an agreement to acquire Baxter Healthcare Corporation's US
generic injectables business for a cash consideration of $112 million.
LONDON, August 26, 2010 - Hikma Pharmaceuticals reports half year profit growth and raises gross
margin guidance.
LONDON, March 17, 2010 - Hikma Pharmaceuticals today announced 2009 preliminary results with
operating profits up 36% on the back of a strong performance from its Middle
East markets.
